When you absolutely have to recruit patients on time.
New study in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
Accell has started a clinical study with 8 sites in Russia in patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Recently, the study has been extended to 16 sites.
This Is Your Team. We Make Clinical Trials Happen.